We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Myovant Sciences, Pfizer Uterine Fibroid Drug Approved
Myovant Sciences, Pfizer Uterine Fibroid Drug Approved
The FDA has approved Myovant Sciences’ and Pfizer’s estrogen-based hormone therapy, Myfembree, for the treatment of heavy menstrual bleeding associated with uterine fibroids, the first once-daily regimen for the condition, according to the companies.